• Home
  • Agric
  • Sci & Tech
  • Health
  • Environment
  • Hausa News
  • More
    • Business/Banking & Finance
    • Politics/Elections
    • Entertainments & Sports
    • International
    • Investigation
    • Law & Human Rights
    • Africa
    • ACCOUNTABILITY/CORRUPTION
    • Hassan Gimba
    • Column
    • Prof. Jibrin Ibrahim
    • Prof. M.K. Othman
    • Defense/Security
    • Education
    • Energy/Electricity
    • Entertainment/Arts & Sports
    • Society and Lifestyle
    • Food & Agriculture
    • Health & Healthy Living
    • International News
    • Interviews
    • Investigation/Fact-Check
    • Judiciary/Legislature/Law & Human Rights
    • Oil & Gas/Mineral Resources
    • Press Freedom/Media/PR/Journalism
    • General News
    • Presidency
  • About Us
    • Contact Us
    • Board Of Advisory
    • Privacy Policy
    • Ethics Policy
    • Teamwork And Collaboration Policy
    • Fact-Checking Policy
    • Advertising
  • Media OutReach Newswire
    • Wire News
  • The Stories
Facebook Twitter Instagram
Trending
  • Nigeria bears highest sickle cell burden, experts warn
  • Education, agriculture programmes free at UNILESA
  • Sokoto–Badagry highway gets Senate approval
  • Ebonyi targets low-immunisation LGAs
  • LG unveils smart dehumidifier for homes, hospitals
  • FX reserves projected at $51.04bn target despite Middle East turmoil, By Hope Moses-Ashike 
  • Senate confirms Yuguda as CBN deputy governor
  • Veterinarians urged to join Nigeria’s public health planning
Facebook Twitter Instagram YouTube
AsheNewsAsheNews
  • Home
  • Agric

    Nigeria loses 24m tonnes of topsoil annually, govt warns

    April 29, 2026

    World agriculture forum inaugurates Nigeria Country council

    April 28, 2026

    U.S. revives GSM-102 credit scheme to deepen agricultural trade with Nigeria

    April 27, 2026

    Poultry farmers seek increased financing to boost production

    April 27, 2026

    Malnutrition: FG rolls out community food bank programme in Northeast

    April 27, 2026
  • Sci & Tech

    Oyedele calls for tech upgrades to boost Nigeria’s growth

    April 29, 2026

    Australian scientists turn plastic waste into clean fuel using sunlight

    April 29, 2026

    Emir Sanusi urges universities to lead AI policy formulation

    April 29, 2026

    Artemis II: Space exploration, and the question of African future, By Prof. M. K. Othman

    April 28, 2026

    Nigeria needs unified cybersecurity – Expert warns

    April 27, 2026
  • Health

    Nigeria bears highest sickle cell burden, experts warn

    April 29, 2026

    Ebonyi targets low-immunisation LGAs

    April 29, 2026

    Enugu intensifies fight against malaria

    April 29, 2026

    Stigma, denial drive HIV rise in Kano

    April 29, 2026

    Kano commences 2026 Africa vaccination week

    April 28, 2026
  • Environment

    Veterinarians urged to join Nigeria’s public health planning

    April 29, 2026

    Nigeria adopts 2026–2035 national nutrition policy

    April 29, 2026

    CTV audience grows over 300% to 8m viewers on GOtv

    April 27, 2026

    Yobe council approves N59.8bn for project, infrastructure

    April 27, 2026

    Rainstorm damages homes, school in Kaduna

    April 27, 2026
  • Hausa News

    Otti plans 250-room 5-star hotel in Umuahia

    April 11, 2026

    Anti-quackery task force seals 4 fake hospitals in Rivers

    August 29, 2025

    [BIDIYO] Yadda na lashe gasa ta duniya a fannin Ingilishi – Rukayya ‘yar shekara 17

    August 6, 2025

    A Saka Baki, A Sasanta Saɓani Tsakanin ‘Yanjarida Da Liman, Daga Muhammad Sajo

    May 21, 2025

    Dan majalisa ya raba kayan miliyoyi a Funtuwa da Dandume

    March 18, 2025
  • More
    1. Business/Banking & Finance
    2. Politics/Elections
    3. Entertainments & Sports
    4. International
    5. Investigation
    6. Law & Human Rights
    7. Africa
    8. ACCOUNTABILITY/CORRUPTION
    9. Hassan Gimba
    10. Column
    11. Prof. Jibrin Ibrahim
    12. Prof. M.K. Othman
    13. Defense/Security
    14. Education
    15. Energy/Electricity
    16. Entertainment/Arts & Sports
    17. Society and Lifestyle
    18. Food & Agriculture
    19. Health & Healthy Living
    20. International News
    21. Interviews
    22. Investigation/Fact-Check
    23. Judiciary/Legislature/Law & Human Rights
    24. Oil & Gas/Mineral Resources
    25. Press Freedom/Media/PR/Journalism
    26. General News
    27. Presidency
    Featured
    Recent

    Nigeria bears highest sickle cell burden, experts warn

    April 29, 2026

    Education, agriculture programmes free at UNILESA

    April 29, 2026

    Sokoto–Badagry highway gets Senate approval

    April 29, 2026
  • About Us
    1. Contact Us
    2. Board Of Advisory
    3. Privacy Policy
    4. Ethics Policy
    5. Teamwork And Collaboration Policy
    6. Fact-Checking Policy
    7. Advertising
    Featured
    Recent

    Nigeria bears highest sickle cell burden, experts warn

    April 29, 2026

    Education, agriculture programmes free at UNILESA

    April 29, 2026

    Sokoto–Badagry highway gets Senate approval

    April 29, 2026
  • Media OutReach Newswire
    • Wire News
  • The Stories
AsheNewsAsheNews
Home»Health & Healthy Living»Migraine-preventing drug significantly reduces rebound headache occurrence
Health & Healthy Living

Migraine-preventing drug significantly reduces rebound headache occurrence

Abdallah el-KurebeBy Abdallah el-KurebeOctober 7, 2024No Comments5 Mins Read
Migraine-prevention drug
Share
Facebook Twitter LinkedIn Pinterest Email

A drug used in the prevention of migraine may also help reduce so-called rebound headaches, according to a new review of data from a randomized, double-blind, placebo-controlled migraine trial.

  • A preventive drug for migraine proves effective at avoiding ‘rebound’ headaches in a new study.
  • The medication is sufficiently effective that people taking it have less need for additional pain meds that can cause rebound headaches.
  • The drug, atogepant, relaxes the blood vessel at which a migraine attack begins, preventing it from becoming too large and irritating the meninges at the bottom of the skull, causing the throbbing pain associated with migraine.

When the drug, atogepant, is taken every day, migraine-related pain can be alleviated, decreasing the need for additional painkillers, believed to be the source of rebound headaches.

The study was led by headache specialist Peter J. Goadsby, MBBS, MD, PhD of King’s College London in the United Kingdom, and a member of the American Academy of Neurology. Its findings appear in the journal Neurology.

Atogepant reduces rebound headaches by 50%

There were 755 participants in the trial, each of whom experienced chronic migraine. Each had at least 15 days of headaches per month, with at least eight qualifying as migraine.

Out of the total group, 66% were overusing pain medications, which often occurs with people attempting to get rid of their headaches.

They were resorting to simple analgesics — such as aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), or acetaminophen — for at least 15 days each month. Some took triptans or ergot alkaloids for at least 10 days. Some took a combination of both for at least 10 days in a month.

The trial began with a 4-week screening/baseline period.

At the beginning of the trial, participants averaged 18 to 19 migraine days per month and were taking medications for pain for 15 to 16 days.

Next, individuals were randomly assigned to take 30 milligrams (mg) of atogepant twice daily, 60 mg of atogepant once each day, or a placebo for 12 weeks. During this period, they were monitored for the frequency of their painkiller use.

Participants who took atogepant took painkillers on fewer days during the trial. Additionally, a higher proportion of participants taking atogepant had a 50% or greater reduction in rebound headaches per month.

What causes migraine and why it’s challenging to treat

In general, said Goadsby, “[m]igraine is an inherited brain disease whose attacks are triggered by changes in the brain and changes in the external environment.”

“We know the path of physiology, but we don’t know what causes a migraine because there are different triggers for different people,” Clifford Segil, DO, a neurologist at Providence Saint John’s Health Center in Santa Monica, CA, who was not involved in the study, told Medical News Today.

“For example,” he said, “many people with red wines versus white wines get it. Many people with cheeses get it. Caffeine both triggers headaches and treats headaches. So we’re still not entirely sure what causes the headaches.”

Modern, pharmaceutical therapies for migraine attacks fall into two camps: preventive and rescue. Atogepant is strictly a preventive drug, though it is closely related to two other drugs — ubrogepant and rimegepant — that are rescue and combination preventive/rescue drugs, respectively.

“Atogepant is a migraine preventive,” said Goadsby. “By taking it every day, the patient has less migraine and a much-reduced need for acute treatments such as painkillers. In effect, it stops the attack before it starts.”

The drug “relaxes the [involved] blood vessel, which makes it get narrower and not as wide, and when it’s not as wide, it feels better,” Segil explained.

What are rebound headaches?

Goadsby also explained rebound headaches and why they occur. He told us that:

“Rebound headache occurs when a medicine taken to relieve an attack wears off and the headache returns. Say you have a migraine that is going to last 2 days. If you take a medicine on day one that lasts for 24 hours, then the headache will return (rebound) the next day, and you need to take another treatment.”

“A big problem with migraines is that people take too much medication, so we can get what’s called a ‘medication overuse headache’ or a ‘rebound’ headache. The easiest example is when someone has some pain, and they take a Motrin, Advil, or Alleve [or some other] NSAID every day,” Segil explained.

Goadsby also cautioned that some pain medications, such as NSAIDs, taken too often, can result in stomach ulcers and other assaults on the digestive tract.

“Taking pain medicines can, paradoxically, increase the number of migraine days the patient has so-called medication overuse headache, so taking fewer pain meds stops that happening,” he said.

According to Segil, overuse of pain meds may never give a migraine attack a chance to go away.

Migraine symptoms: What to know

A migraine is a severe headache that is classically characterized by throbbing pain, sometimes covering half the head.

It may be accompanied by an uncomfortable sensitivity to bright lights and loud noises — photophobia or phonophobia, respectively — with or without blurry vision or a visual aura, a difficult-to-describe symptom in which vision becomes prismatic.

“Generally speaking, when people get migraines, there is a blood vessel between the brain and the skull in your meninges, and when the blood vessel gets too big, it dilates. It tugs on the meninges [which is] the shock absorber of the brain. That usually causes the throbbing pain,” Segil explained.

“After that, there’s irritation of the cortex of the brain, and a wave of electricity called cortical spreading depression, and that’s usually the radiating pain,” he detailed.

By Robby Berman, MedicalNewsToday

Migraine-preventing drug
Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
Abdallah el-Kurebe
  • Website
  • Facebook
  • Twitter
  • LinkedIn

Related Posts

Nigeria bears highest sickle cell burden, experts warn

April 29, 2026

Ebonyi targets low-immunisation LGAs

April 29, 2026

Enugu intensifies fight against malaria

April 29, 2026

Leave A Reply Cancel Reply

Nigeria bears highest sickle cell burden, experts warn

April 29, 2026

Education, agriculture programmes free at UNILESA

April 29, 2026

Sokoto–Badagry highway gets Senate approval

April 29, 2026

Ebonyi targets low-immunisation LGAs

April 29, 2026
About Us
About Us

ASHENEWS (AsheNewsDaily.com), published by PenPlus Online Media Publishers, is an independent online newspaper. We report development news, especially on Agriculture, Science, Health and Environment as they affect the under-reported rural and urban poor.

We also conduct investigations, especially in the areas of ASHE, as well as other general interests, including corruption, human rights, illicit financial flows, and politics.

Contact Info:
  • 1st floor, Dogon Daji House, No. 5, Maiduguri Road, Sokoto
  • +234(0)7031140009
  • ashenewsdaily@gmail.com
Facebook Twitter Instagram Pinterest
© 2026 All Rights Reserved. ASHENEWS Daily Designed & Managed By DeedsTech

Type above and press Enter to search. Press Esc to cancel.